Cargando…

Factors associated with late recurrence after completion of 5-year adjuvant tamoxifen in estrogen receptor positive breast cancer

BACKGROUND: Recent large trials have shown the survival benefits of 10-year use of tamoxifen by reducing late recurrence compared with 5-year therapy in estrogen receptor(ER)-positive breast cancer. We tried to identify clinical factors associated with the late recurrence. METHODS: We reviewed our d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Eun-Shin, Han, Wonshik, Kim, Min Kyoon, Kim, Jongjin, Yoo, Tae-kyung, Lee, Moo Hyun, Lee, Kyung Hun, Kim, Tae Yong, Moon, Hyeong-Gon, Im, Seock-Ah, Noh, Dong-Young, Lee, Eun Sook
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937609/ https://www.ncbi.nlm.nih.gov/pubmed/27388210 http://dx.doi.org/10.1186/s12885-016-2423-x

Ejemplares similares

Delay of Treatment Initiation Does Not Adversely Affect Survival Outcome in Breast Cancer
por: Yoo, Tae-Kyung, et al.
Publicado: (2016)

Nomogram for Predicting Breast Conservation after Neoadjuvant Chemotherapy
por: Kim, Min Kyoon, et al.
Publicado: (2015)

Predictive Significance of p53, Ki-67, and Bcl-2 Expression for Pathologic Complete Response after Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer
por: Kim, Taeryung, et al.
Publicado: (2015)

Risk Factors Associated with Distant Metastasis and Survival Outcomes in Breast Cancer Patients with Locoregional Recurrence
por: Park, Soojin, et al.
Publicado: (2015)

Leptin as a Potential Target for Estrogen Receptor-Positive Breast Cancer
por: Yom, Cha Kyong, et al.
Publicado: (2013)

In Vivo Tumor Growth Rate Measured by US in Preoperative Period and Long Term Disease Outcome in Breast Cancer Patients
por: Yoo, Tae-Kyung, et al.
Publicado: (2015)

Association of Insulin, Metformin, and Statin with Mortality in Breast Cancer Patients
por: Choi, Mihong, et al.
Publicado: (2021)

Ki-67 Expression is a Significant Prognostic Factor Only When Progesterone Receptor Expression is Low in Estrogen Receptor-Positive and HER2-Negative Early Breast Cancer
por: Kang, Young-Joon, et al.
Publicado: (2019)

Intensity of metastasis screening and survival outcomes in patients with breast cancer
por: Cheun, Jong-Ho, et al.
Publicado: (2021)

The Clinical Significance and Molecular Features of the Spatial Tumor Shapes in Breast Cancers
por: Moon, Hyeong-Gon, et al.
Publicado: (2015)

Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancer
por: Kim, Jisun, et al.
Publicado: (2012)

Can We Skip Intraoperative Evaluation of Sentinel Lymph Nodes? Nomogram Predicting Involvement of Three or More Axillary Lymph Nodes before Breast Cancer Surgery
por: Ahn, Soo Kyung, et al.
Publicado: (2017)

Efficacy of Letrozole as First-Line Treatment of Postmenopausal Women with Hormone Receptor–Positive Metastatic Breast Cancer in Korea
por: Beom, Seung Hoon, et al.
Publicado: (2017)

Effect of Time Interval between Breast-Conserving Surgery and Radiation Therapy on Outcomes of Node-Positive Breast Cancer Patients Treated with Adjuvant Doxorubicin/Cyclophosphamide Followed by Taxane
por: Koh, Hyeon Kang, et al.
Publicado: (2016)

Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy
por: Lee, Kyung-Hun, et al.
Publicado: (2007)

Prognostic impact of AJCC response criteria for neoadjuvant chemotherapy in stage II/III breast cancer patients: breast cancer subtype analyses
por: Yang, Yaewon, et al.
Publicado: (2016)

Prognostic Role of Androgen Receptor Expression in Surgically Resected Early Breast Cancer Patients
por: Yang, Yaewon, et al.
Publicado: (2020)

Effect of Timing of Gonadotropin-Releasing Hormone Agonist Administration for Ovarian Protection in Patients with Breast Cancer
por: Shin, Jae Jun, et al.
Publicado: (2020)

Amenorrhea and Menopause in Patients with Breast Cancer after Chemotherapy
por: Shin, Jae Jun, et al.
Publicado: (2019)

Genomic alterations identified by array comparative genomic hybridization as prognostic markers in tamoxifen-treated estrogen receptor-positive breast cancer
por: Han, Wonshik, et al.
Publicado: (2006)

Musculoskeletal Pain and the Prevalence of Rheumatoid Arthritis in Breast Cancer Patients During Cancer Treatment: A Retrospective Study
por: Kim, Ju Yeon, et al.
Publicado: (2022)

Accelerated whole breast irradiation in early breast cancer patients with adverse prognostic features
por: Lee, Sea-Won, et al.
Publicado: (2016)

Effects of tamoxifen and aromatase inhibitors on the risk of acute coronary syndrome in elderly breast cancer patients: An analysis of nationwide data
por: Choi, Sung Hyouk, et al.
Publicado: (2020)

Splenomegaly and Its Associations with Genetic Polymorphisms and Treatment Outcome in Colorectal Cancer Patients Treated with Adjuvant FOLFOX
por: Kim, Mi-Jung, et al.
Publicado: (2016)

Detection of Germline Mutations in Breast Cancer Patients with Clinical Features of Hereditary Cancer Syndrome Using a Multi-Gene Panel Test
por: Shin, Hee-Chul, et al.
Publicado: (2020)

Efficacy of Exemestane in Korean Patients with Metastatic Breast Cancer after Failure of Nonsteroidal Aromatase Inhibitors
por: Lee, June Koo, et al.
Publicado: (2013)

Adenoid Cystic Carcinoma of the Breast: A Case Series of Six Patients and Literature Review
por: Kim, Miso, et al.
Publicado: (2014)

A Comparative Study of Daily 3-Gy Hypofractionated and 1.8-Gy Conventional Breast Irradiation in Early-Stage Breast Cancer
por: Lee, Sea-Won, et al.
Publicado: (2016)

Correction: Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancer
por: Kim, Jisun, et al.
Publicado: (2012)

Prognostic effect of preoperative serum estradiol level in postmenopausal breast cancer
por: Kim, Ju-Yeon, et al.
Publicado: (2013)

Bilateral Salpingo-oophorectomy Compared to Gonadotropin-Releasing Hormone Agonists in Premenopausal Hormone Receptor?Positive Metastatic Breast Cancer Patients Treated with Aromatase Inhibitors
por: Suh, Koung Jin, et al.
Publicado: (2017)

Immune recurrence score using 7 immunoregulatory protein expressions can predict recurrence in stage I–III breast cancer patients
por: Lee, Dae-Won, et al.
Publicado: (2019)

Expression of Immunohistochemical Markers before and after Neoadjuvant Chemotherapy in Breast Carcinoma, and Their Use as Predictors of Response
por: Lee, Ho-chang, et al.
Publicado: (2013)

Endocrine Treatment-Related Symptoms and Patient Outcomes in Breast Cancer: A Meta-Analysis
por: Yoo, Tae-Kyung, et al.
Publicado: (2018)

A New Isolated Mediastinal Lymph Node or Small Pulmonary Nodule Arising during Breast Cancer Surveillance Following Curative Surgery: Clinical Factors That Differentiate Malignant from Benign Lesions
por: Kim, Tae-Yong, et al.
Publicado: (2014)

The treatment outcomes and the use of adjuvant therapies in breast cancer patients with severe co-morbidities
por: Han, Jaihong, et al.
Publicado: (2017)

The Emotional Status, Attitudes in Decision-Making Process, and Their Impact on Surgical Choices in Korean Breast Cancer Patients
por: Jeon, Sook Young, et al.
Publicado: (2021)

ABCB1 polymorphism as prognostic factor in breast cancer patients treated with docetaxel and doxorubicin neoadjuvant chemotherapy
por: Kim, Hee-Jun, et al.
Publicado: (2015)

Survival Outcomes According to Adjuvant Treatment and Prognostic Factors Including Host Immune Markers in Patients with Curatively Resected Ampulla of Vater Cancer
por: Ha, Hye rim, et al.
Publicado: (2016)

Enhanced anti-tumor activity and cytotoxic effect on cancer stem cell population of metformin-butyrate compared with metformin HCl in breast cancer
por: Lee, Kyung-Min, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_5o3l8e89mg99bass0rumfggmsa